KIR2DL2/2DL3-E35 alleles are functionally stronger than -Q35 alleles

An Improved Method With High Specificity forKIR2DL1Functional Allele Typing

(2015) Rafijul Bari et al.   Labmedicine

An Improved Method With High Specificity forKIR2DL1Functional Allele Typing

(2015) Rafijul Bari et al.   LABORATORY MEDICINE

Infusions of Allogeneic Natural Killer Cells as Cancer Therapy

(2014) W. Leung   CLINICAL CANCER RESEARCH

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

(2014) A. K. Moesta et al.   JOURNAL OF IMMUNOLOGY

The IPD and IMGT/HLA database: allele variant databases

(2014) James Robinson et al.   NUCLEIC ACIDS RESEARCH

Effect of Donor KIR2DL1 Allelic Polymorphism on the Outcome of Pediatric Allogeneic Hematopoietic Stem-Cell Transplantation

(2013) Rafijul Bari et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiplex and Genome-Wide Analyses Reveal Distinctive Properties of KIR+ and CD56+ T Cells in Human Blood

(2013) W. K. Chan et al.   JOURNAL OF IMMUNOLOGY

Allelic Variation in KIR2DL3 Generates a KIR2DL2-like Receptor with Increased Binding to its HLA-C Ligand

(2013) W. R. Frazier et al.   JOURNAL OF IMMUNOLOGY

Molecular determinant-based typing of KIR alleles and KIR ligands

(2011) Rafijul Bari et al.   CLINICAL IMMUNOLOGY

Killer Immunoglobulin-Like Receptor Transcriptional Regulation: A Fascinating Dance of Multiple Promoters

(2011) Frank Cichocki et al.   Journal of Innate Immunity

Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition

(2010) K. Schonberg et al.   BLOOD

Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus

(2010) Chul-Woo Pyo et al.   PLoS One

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis

(2009) Åslaug R. Lorentzen et al.   ANNALS OF NEUROLOGY

Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245

(2009) R. Bari et al.   BLOOD

KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression

(2009) S. Andersson et al.   BLOOD

Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex

(2009) James A. Traherne et al.   HUMAN MOLECULAR GENETICS

Susceptibility to Crohn’s disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand

(2009) Jill A. Hollenbach et al.   IMMUNOGENETICS

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome

(2009) D. P. Lowe et al.   RHEUMATOLOGY

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia

(2009) D. Middleton et al.   TISSUE ANTIGENS

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals

(2008) R D Levinson et al.   GENES AND IMMUNITY

Association of killer cell immunoglobulin–like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus

(2008) SMA Toloza et al.   LUPUS

The Yin and Yang of HLA and KIR in human disease

(2008) Smita Kulkarni et al.   SEMINARS IN IMMUNOLOGY